Item Type | Name |
Academic Article
|
A novel approach to the identification and quantitative elemental analysis of amyloid deposits--insights into the pathology of Alzheimer's disease.
|
Academic Article
|
Reexamining Alzheimer's disease: evidence for a protective role for amyloid-beta protein precursor and amyloid-beta.
|
Academic Article
|
Amyloid-beta-derived diffusible ligands cause impaired axonal transport of mitochondria in neurons.
|
Academic Article
|
NMR studies of zinc, copper, and iron binding to histidine, the principal metal ion complexing site of amyloid-beta peptide.
|
Academic Article
|
Novel therapeutics for Alzheimer's disease: an update.
|
Academic Article
|
Upregulation of presenilin 1 in brains of sporadic, late-onset Alzheimer's disease.
|
Academic Article
|
Signaling effect of amyloid-beta(42) on the processing of AbetaPP.
|
Academic Article
|
Dissociated amyloid-beta antibody levels as a serum biomarker for the progression of Alzheimer's disease: a population-based study.
|
Academic Article
|
Evidence for the progression through S-phase in the ectopic cell cycle re-entry of neurons in Alzheimer disease.
|
Academic Article
|
Memantine: "hypothesis testing" not "disease modifying" in Alzheimer's disease.
|
Academic Article
|
Intraneuronal amyloid beta accumulation and oxidative damage to nucleic acids in Alzheimer disease.
|
Academic Article
|
Specific reaction of Met 35 in amyloid beta peptide with hypochlorous acid.
|
Academic Article
|
Biomarkers in Alzheimer's disease: past, present and future.
|
Academic Article
|
Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis.
|
Academic Article
|
Autophagy in Alzheimer's disease.
|
Academic Article
|
Elevation of {beta}-amyloid 1-42 autoantibodies in the blood of amnestic patients with mild cognitive impairment.
|
Academic Article
|
AGEs/RAGE complex upregulates BACE1 via NF-?B pathway activation.
|
Academic Article
|
Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease.
|
Academic Article
|
Cellular prion protein is essential for oligomeric amyloid-?-induced neuronal cell death.
|
Academic Article
|
Amyloid-? peptide structure in aqueous solution varies with fragment size.
|
Academic Article
|
Structures and free energy landscapes of aqueous zinc(II)-bound amyloid-?(1-40) and zinc(II)-bound amyloid-?(1-42) with dynamics.
|
Academic Article
|
The contribution of the amyloid hypothesis to the understanding of Alzheimer's disease: a critical overview.
|
Academic Article
|
The structures of the E22? mutant-type amyloid-? alloforms and the impact of E22? mutation on the structures of the wild-type amyloid-? alloforms.
|
Academic Article
|
Amyloid ? peptides modify the expression of antioxidant repair enzymes and a potassium channel in the septohippocampal system.
|
Academic Article
|
Modification of amyloid-?1-42 fibril structure by methionine-35 oxidation.
|
Academic Article
|
Intrahippocampal amyloid-? (1-40) injections injure medial septal neurons in rats.
|
Academic Article
|
Amyloid Beta and tau proteins as therapeutic targets for Alzheimer's disease treatment: rethinking the current strategy.
|
Academic Article
|
Mitochondrial abnormalities in a streptozotocin-induced rat model of sporadic Alzheimer's disease.
|
Academic Article
|
Plaques and tangles: birthmarks of the aging soul. Preface.
|
Academic Article
|
Islet amyloid polypeptide (IAPP): a second amyloid in Alzheimer's disease.
|
Academic Article
|
Alzheimer Disease Pathology in Middle Age Reveals a Spatial-Temporal Disconnect Between Amyloid-? and Phosphorylated Tau.
|
Academic Article
|
Curcumin/melatonin hybrid 5-(4-hydroxy-phenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide ameliorates AD-like pathology in the APP/PS1 mouse model.
|
Academic Article
|
Accumulation of intraneuronal amyloid-? is common in normal brain.
|
Academic Article
|
Mitochondrial traffic jams in Alzheimer's disease - pinpointing the roadblocks.
|
Academic Article
|
Tau, Amyloid Beta and Deep Brain Stimulation: Aiming to Restore Cognitive Deficit in Alzheimer's Disease.
|
Academic Article
|
Identification of Inhibitors of CD36-Amyloid Beta Binding as Potential Agents for Alzheimer's Disease.
|
Academic Article
|
Elongation affinity, activation barrier, and stability of A?42 oligomers/fibrils in physiological saline.
|
Academic Article
|
Laser-Induced In-Source Decay Applied to the Determination of Amyloid-Beta in Alzheimer's Brains.
|
Academic Article
|
Fibrillar Amyloid-? Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3?Tg-AD Transgenic Mouse.
|
Academic Article
|
High-resolution analytical imaging and electron holography of magnetite particles in amyloid cores of Alzheimer's disease.
|
Academic Article
|
Beta-amyloid 1-42 monomers, but not oligomers, produce PHF-like conformation of Tau protein.
|
Academic Article
|
Inhibition of mitochondrial fragmentation protects against Alzheimer's disease in rodent model.
|
Academic Article
|
Thermodynamics of Amyloid-? Fibril Elongation: Atomistic Details of the Transition State.
|
Academic Article
|
Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-? Deposition in the APPSWE/PS1dE9 Mouse Model of Alzheimer's Disease Pathology.
|
Academic Article
|
Precision pharmacology for Alzheimer's disease.
|
Academic Article
|
Analysis of post-translational modifications in Alzheimer's disease by mass spectrometry.
|
Academic Article
|
The sterol regulatory element-binding protein 2 is dysregulated by tau alterations in Alzheimer disease.
|
Academic Article
|
Incubation with Cu(II) and Zn(II) salts enhances MALDI-TOF mass spectra of amyloid-beta and a-synuclein toward in vivo analysis.
|
Academic Article
|
Characterization of Proteins Present in Isolated Senile Plaques from Alzheimer's Diseased Brains by MALDI-TOF MS with MS/MS.
|
Academic Article
|
Rab10 Phosphorylation is a Prominent Pathological Feature in Alzheimer's Disease.
|
Academic Article
|
Nanoscale synchrotron X-ray speciation of iron and calcium compounds in amyloid plaque cores from Alzheimer's disease subjects.
|
Academic Article
|
Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.
|
Academic Article
|
The amyloid cascade and Alzheimer's disease therapeutics: theory versus observation.
|
Academic Article
|
TDP-43 inhibitory peptide alleviates neurodegeneration and memory loss in an APP transgenic mouse model for Alzheimer's disease.
|
Academic Article
|
Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances.
|
Academic Article
|
Decreased salivary lactoferrin levels are specific to Alzheimer's disease.
|
Academic Article
|
Amyloid-beta, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs?
|
Academic Article
|
Predicting the failure of amyloid-beta vaccine.
|
Academic Article
|
Dangers of the amyloid-beta vaccination.
|
Academic Article
|
The neuroprotective activities of melatonin against the Alzheimer beta-protein are not mediated by melatonin membrane receptors.
|
Academic Article
|
Senile plaque composition and posttranslational modification of amyloid-beta peptide and associated proteins.
|
Academic Article
|
Cholesterol, oxidative stress, and Alzheimer's disease: expanding the horizons of pathogenesis.
|
Academic Article
|
Ill-fated amyloid-beta vaccine.
|
Academic Article
|
The state versus amyloid-beta: the trial of the most wanted criminal in Alzheimer disease.
|
Academic Article
|
Labeling of cerebral amyloid beta deposits in vivo using intranasal basic fibroblast growth factor and serum amyloid P component in mice.
|
Academic Article
|
Amyloid-beta: a (life) preserver for the brain.
|
Academic Article
|
Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice.
|
Academic Article
|
Role of high mobility group protein-1 (HMG1) in amyloid-beta homeostasis.
|
Academic Article
|
The role of mitogen-activated protein kinase pathways in Alzheimer's disease.
|
Academic Article
|
Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease.
|
Academic Article
|
Amyloid-beta: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-beta.
|
Academic Article
|
Cerebrovascular requirement for sealant, anti-coagulant and remodeling molecules that allow for the maintenance of vascular integrity and blood supply.
|
Academic Article
|
Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
|
Academic Article
|
Alzheimer's disease: the two-hit hypothesis.
|
Academic Article
|
Challenging the amyloid cascade hypothesis: senile plaques and amyloid-beta as protective adaptations to Alzheimer disease.
|
Academic Article
|
Microglial activation and amyloid-beta clearance induced by exogenous heat-shock proteins.
|
Academic Article
|
Call for Elan to publish Alzheimer's trial details.
|
Academic Article
|
Oxidative stress increases expression and activity of BACE in NT2 neurons.
|
Academic Article
|
Amyloid-beta: a vascular sealant that protects against hemorrhage?
|
Academic Article
|
Amyloid-beta and tau serve antioxidant functions in the aging and Alzheimer brain.
|
Academic Article
|
Iron: a pathological mediator of Alzheimer disease?
|
Academic Article
|
Cerebral hemorrhage and amyloid-beta.
|
Academic Article
|
Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence.
|
Academic Article
|
Will preventing protein aggregates live up to its promise as prophylaxis against neurodegenerative diseases?
|
Academic Article
|
Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease.
|
Academic Article
|
Tipping the apoptotic balance in Alzheimer's disease: the abortosis concept.
|
Academic Article
|
Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta.
|
Academic Article
|
Amyloid-beta-induced toxicity of primary neurons is dependent upon differentiation-associated increases in tau and cyclin-dependent kinase 5 expression.
|
Academic Article
|
Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition.
|
Academic Article
|
Perspectives on the amyloid-beta cascade hypothesis.
|
Academic Article
|
Oxidative stress and redox-active iron in Alzheimer's disease.
|
Academic Article
|
Neuroprotective properties of Bcl-w in Alzheimer disease.
|
Academic Article
|
Cerebral amyloid angiopathy: major contributor or decorative response to Alzheimer's disease pathogenesis.
|
Academic Article
|
Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease.
|
Academic Article
|
Mitochondrial failures in Alzheimer's disease.
|
Academic Article
|
Therapeutic potential of oxidant mechanisms in Alzheimer's disease.
|
Academic Article
|
Therapeutic opportunities in Alzheimer disease: one for all or all for one?
|
Academic Article
|
Amyloid-beta in Alzheimer's disease: the horse or the cart? Pathogenic or protective?
|
Academic Article
|
The cell cycle in Alzheimer disease: a unique target for neuropharmacology.
|
Academic Article
|
A second look into the oxidant mechanisms in Alzheimer's disease.
|
Academic Article
|
P38 activation mediates amyloid-beta cytotoxicity.
|
Academic Article
|
Amyloid beta: the alternate hypothesis.
|
Academic Article
|
Neuropathology in Alzheimer's disease: awaking from a hundred-year-old dream.
|
Academic Article
|
Neuropathology of Alzheimer disease: pathognomonic but not pathogenic.
|
Academic Article
|
Amyloid-beta vaccination: testing the amyloid hypothesis?: heads we win, tails you lose!
|
Academic Article
|
Alzheimer disease, the two-hit hypothesis: an update.
|
Academic Article
|
Amyloid-beta in Alzheimer disease: the null versus the alternate hypotheses.
|
Academic Article
|
Treating the lesions, not the disease.
|
Academic Article
|
Beyond estrogen: targeting gonadotropin hormones in the treatment of Alzheimer's disease.
|
Academic Article
|
Staying connected: synapses in Alzheimer disease.
|
Academic Article
|
Drug therapy in Alzheimer's disease.
|
Academic Article
|
Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease.
|
Academic Article
|
Alzheimer's disease: an intracellular movement disorder?
|
Academic Article
|
Redox metals and oxidative abnormalities in human prion diseases.
|
Academic Article
|
Chitin-like polysaccharides in Alzheimer's disease brains.
|
Academic Article
|
The fallacy of amyloid and cognition in Alzheimer's disease.
|
Academic Article
|
Compensatory responses induced by oxidative stress in Alzheimer disease.
|
Academic Article
|
Antioxidant protection and neurodegenerative disease: the role of amyloid-beta and tau.
|
Academic Article
|
Therapeutic options in Alzheimer's disease.
|
Academic Article
|
Amyloid-beta, BACE, and oxidative stress in Alzheimer's disease, a commentary on "The different aggregation state of beta-amyloid 1-42 mediates different effects on oxidative stress, neurodegeneration and BACE-1 expression".
|
Academic Article
|
Involvement of oxidative stress in Alzheimer disease.
|
Academic Article
|
Increased expression of p130 in Alzheimer disease.
|
Academic Article
|
Neuropathology and treatment of Alzheimer disease: did we lose the forest for the trees?
|
Academic Article
|
Lipid peroxidation and 4-hydroxy-2-nonenal formation by copper ion bound to amyloid-beta peptide.
|
Academic Article
|
Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein.
|
Academic Article
|
Insights into amyloid-beta-induced mitochondrial dysfunction in Alzheimer disease.
|
Academic Article
|
The contribution of luteinizing hormone to Alzheimer disease pathogenesis.
|
Academic Article
|
Antigen-antibody dissociation in Alzheimer disease: a novel approach to diagnosis.
|
Academic Article
|
Antibodies to potato virus Y bind the amyloid beta peptide: immunohistochemical and NMR studies.
|
Academic Article
|
Alzheimer disease pathology as a host response.
|
Academic Article
|
Three-dimensional tomographic imaging and characterization of iron compounds within Alzheimer's plaque core material.
|
Academic Article
|
Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease.
|
Academic Article
|
Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease.
|
Academic Article
|
The up-regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1alpha.
|
Academic Article
|
Molecular pathogenesis of Alzheimer's disease: reductionist versus expansionist approaches.
|
Academic Article
|
Nanoparticle-chelator conjugates as inhibitors of amyloid-beta aggregation and neurotoxicity: a novel therapeutic approach for Alzheimer disease.
|
Academic Article
|
Impaired balance of mitochondrial fission and fusion in Alzheimer's disease.
|
Academic Article
|
Iron: the Redox-active center of oxidative stress in Alzheimer disease.
|
Academic Article
|
Three histidine residues of amyloid-beta peptide control the redox activity of copper and iron.
|
Academic Article
|
The role of novel chitin-like polysaccharides in Alzheimer disease.
|
Academic Article
|
Current approaches in the treatment of Alzheimer's disease.
|
Academic Article
|
From aging to Alzheimer's disease: unveiling "the switch" with the senescence-accelerated mouse model (SAMP8).
|
Concept
|
Amyloid
|
Concept
|
Serum Amyloid P-Component
|
Concept
|
Serum Amyloid A Protein
|
Concept
|
Amyloid beta-Protein Precursor
|
Concept
|
Cerebral Amyloid Angiopathy
|
Concept
|
Cerebral Amyloid Angiopathy, Familial
|
Concept
|
Amyloid Precursor Protein Secretases
|
Academic Article
|
?-amyloid 1-42 induces physiological transcriptional regulation of BACE1.
|
Academic Article
|
Tackling the elusive challenges relevant to conquering the 100-plus year old problem of Alzheimer's disease.
|
Academic Article
|
Microbes and Alzheimer's Disease.
|
Academic Article
|
Overview of Alzheimer's Disease and Some Therapeutic Approaches Targeting A? by Using Several Synthetic and Herbal Compounds.
|
Academic Article
|
Neuroinflammation, hyperphosphorylated tau, diffuse amyloid plaques, and down-regulation of the cellular prion protein in air pollution exposed children and young adults.
|
Academic Article
|
Status and future directions of clinical trials in Alzheimer's disease.
|
Academic Article
|
Serial reconstruction of beta-protein amyloid plaques: relationship to microvessels and size distribution.
|
Academic Article
|
Senile plaques in cerebral amyloid angiopathy show accumulation of amyloid precursor protein without cytoskeletal abnormalities.
|
Academic Article
|
Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein.
|
Academic Article
|
Ultrastructural localization of beta-amyloid, tau, and ubiquitin epitopes in extracellular neurofibrillary tangles.
|
Academic Article
|
Association of heparan sulfate proteoglycan with the neurofibrillary tangles of Alzheimer's disease.
|
Academic Article
|
Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease.
|
Academic Article
|
Soluble derivatives of the beta amyloid protein precursor of Alzheimer's disease are labeled by antisera to the beta amyloid protein.
|
Academic Article
|
Immunolocalization of the amyloid precursor protein within the senile plaque.
|
Academic Article
|
Amyloid precursor protein in senile plaques of Alzheimer disease.
|
Academic Article
|
The amyloid percursor protein of Alzheimer disease is expressed as a 130 kDa polypeptide in various cultured cell types.
|
Academic Article
|
Acetylcholinesterase and its association with heparan sulphate proteoglycans in cortical amyloid deposits of Alzheimer's disease.
|
Academic Article
|
Subcellular localization of amyloid precursor protein in senile plaques of Alzheimer's disease.
|
Academic Article
|
Beta protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer's disease.
|
Academic Article
|
Dystrophic neurites infiltrate extracellular neurofibrillary tangles in Alzheimer disease.
|
Academic Article
|
Widespread serum amyloid P immunoreactivity in cortical amyloid deposits and the neurofibrillary pathology of Alzheimer's disease and other degenerative disorders.
|
Academic Article
|
The relationship of amyloid plaques to cerebral capillaries in Alzheimer's disease.
|
Academic Article
|
The widespread alteration of neurites in Alzheimer's disease may be unrelated to amyloid deposition.
|
Academic Article
|
Amyloid precursor protein in cell cultures: a 130 kDa polypeptide.
|
Academic Article
|
Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide.
|
Academic Article
|
Apolipoprotein E epsilon 4 allele frequency is not increased in progressive supranuclear palsy.
|
Academic Article
|
Alzheimer's disease and prion proteins: a meeting made in muscle.
|
Academic Article
|
Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease.
|
Academic Article
|
The amyloid precursor protein in ischemic brain injury and chronic hypoperfusion.
|
Academic Article
|
beta PP and Tau interaction. A possible link between amyloid and neurofibrillary tangles in Alzheimer's disease.
|
Academic Article
|
APP transgenesis: approaches toward the development of animal models for Alzheimer disease neuropathology.
|
Academic Article
|
Artifactual strain-specific signs of incipient brain amyloidosis in APP transgenic mice.
|
Academic Article
|
Filament heterogeneity within the dystrophic neurites of senile plaques suggests blockage of fast axonal transport in Alzheimer's disease.
|
Academic Article
|
Trypsin interaction with the senile plaques of Alzheimer disease is mediated by beta-protein precursor.
|
Academic Article
|
The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis.
|
Academic Article
|
Association of apolipoprotein E with murine amyloid A protein amyloid.
|
Academic Article
|
Immunocytochemical evidence that the beta-protein precursor is an integral component of neurofibrillary tangles of Alzheimer's disease.
|
Academic Article
|
Amyloid P component and other acute-phase proteins associated with cerebellar A beta-deposits in Alzheimer's disease.
|
Academic Article
|
Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease: implications for disease pathogenesis.
|
Academic Article
|
Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer's disease.
|
Academic Article
|
beta-Amyloid of Alzheimer's disease induces reactive gliosis that inhibits axonal outgrowth.
|
Academic Article
|
Neuritic plaques in Alzheimer disease originate from neurofibrillary tangles.
|
Academic Article
|
Identification and transport of full-length amyloid precursor proteins in rat peripheral nervous system.
|
Academic Article
|
Accumulation of the beta amyloid precursor protein at sites of ischemic injury in rat brain.
|
Academic Article
|
Rimmed vacuoles of inclusion body myositis and oculopharyngeal muscular dystrophy contain amyloid precursor protein and lysosomal markers.
|
Academic Article
|
Is amyloid beta-protein glycated in Alzheimer's disease?
|
Academic Article
|
Mechanisms of neurotoxicity associated with amyloid beta deposition and the role of free radicals in the pathogenesis of Alzheimer's disease: a critical appraisal.
|
Academic Article
|
Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo.
|
Academic Article
|
Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress.
|
Academic Article
|
Altered glycosylation pattern of proteins in Alzheimer disease.
|
Academic Article
|
Redox metals and neurodegenerative disease.
|
Academic Article
|
In situ methods for detection and localization of markers of oxidative stress: application in neurodegenerative disorders.
|
Academic Article
|
Serum amyloid P is not present in amyloid beta deposits of a transgenic animal model.
|
Academic Article
|
Amyloid-beta junkies.
|
Academic Article
|
Copernicus revisited: amyloid beta in Alzheimer's disease.
|
Academic Article
|
Redox-active iron mediates amyloid-beta toxicity.
|
Academic Article
|
Melatonin reduces interleukin secretion in amyloid-beta stressed mouse brain slices.
|
Academic Article
|
Induction of NADPH cytochrome P450 reductase by the Alzheimer beta-protein. Amyloid as a "foreign body".
|
Academic Article
|
Protocol for quantitative analysis of paired helical filament solubilization: a method applicable to insoluble amyloids and inclusion bodies.
|
Academic Article
|
Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease.
|
Academic Article
|
Early glycoxidation damage in brains from Down's syndrome.
|
Academic Article
|
Is oxidative damage central to the pathogenesis of Alzheimer disease?
|
Academic Article
|
In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals.
|
Academic Article
|
Neuronal RNA oxidation in Alzheimer's disease and Down's syndrome.
|
Academic Article
|
Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc.
|
Academic Article
|
Prospects for noninvasive imaging of brain amyloid beta in Alzheimer's disease.
|
Academic Article
|
Oxidative stress in Alzheimer's disease.
|
Academic Article
|
Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome.
|
Academic Article
|
Melatonin acts as antioxidant and pro-oxidant in an organotypic slice culture model of Alzheimer's disease.
|
Academic Article
|
Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB.
|
Academic Article
|
Oxidative stress and predominant Abeta42(43) deposition in myopathies with rimmed vacuoles.
|
Academic Article
|
Oxidative damage is the earliest event in Alzheimer disease.
|
Academic Article
|
Therapeutic potential in Alzheimer disease.
|
Academic Article
|
Possible involvement of ER chaperone Grp78 on reduced formation of amyloid-beta deposits.
|
Academic Article
|
Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways.
|
Academic Article
|
Retinoic acid isomers protect hippocampal neurons from amyloid-beta induced neurodegeneration.
|
Academic Article
|
Synaptic dysfunction and oxidative stress in Alzheimer's disease: emerging mechanisms.
|
Academic Article
|
Brain and brawn: parallels in oxidative strength.
|
Academic Article
|
Trace copper levels in the drinking water, but not zinc or aluminum influence CNS Alzheimer-like pathology.
|
Academic Article
|
Oxidative stress signaling in Alzheimer's disease.
|
Academic Article
|
Prospects on the origin of Alzheimer's disease.
|
Academic Article
|
Dysfunctional tubular endoplasmic reticulum constitutes a pathological feature of Alzheimer's disease.
|
Grant
|
AMYLOID PRECURSOR IN ALZHEIMER DISEASE
|
Grant
|
AMYLOID PRECURSOR IN ALZHEIMER DISEASE
|
Academic Article
|
Ethanol-Fixed, Paraffin-Embedded Tissue Imaging: Implications for Alzheimer's Disease Research.
|
Academic Article
|
A Multilevel View of the Development of Alzheimer's Disease.
|
Academic Article
|
Immune modulations and immunotherapies for Alzheimer's disease: a comprehensive review.
|
Academic Article
|
Lessons from antiamyloid-? immunotherapies in Alzheimer's disease.
|
Academic Article
|
The Amyloid-? Pathway in Alzheimer's Disease.
|
Academic Article
|
Neuropathologic Changes Provide Insights into Key Mechanisms of Alzheimer Disease and Related Dementia.
|
Academic Article
|
Playing Russian Roulette with Alzheimer's Disease Patients: Do the Cognitive Benefits of Lecanemab Outweigh the Risk of Edema, Stroke and Encephalitis?
|
Academic Article
|
The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes.
|
Academic Article
|
Passive Alzheimer's immunotherapy: A promising or uncertain option?
|
Academic Article
|
FDG-PET versus Amyloid-PET Imaging for Diagnosis and Response Evaluation in Alzheimer's Disease: Benefits and Pitfalls.
|
Academic Article
|
The amyloid-? pathway in Alzheimer's disease: a plain language summary.
|
Academic Article
|
MRI Monitoring of Anti-Alzheimer Therapy Amyloid-Related Imaging Abnormalities: Due Diligence or Overkill?
|
Academic Article
|
Revision of Alzheimer's diagnostic criteria or relocation of the Potemkin village.
|
Academic Article
|
Association of COVID-19 with Risk and Progression of Alzheimer's Disease: Non-Overlapping Two-Sample Mendelian Randomization Analysis of 2.6 Million Subjects.
|
Academic Article
|
Evaluation of N- and O-Linked Indole Triazines for a Dual Effect on a-Synuclein and Tau Aggregation.
|